Table 3.
Outcome of self-expanding metal stents placement according to the presence of carcinomatosis
|
Total |
Without PC |
With PC |
P value | ||||
| n | % | n | % | n | % | ||
| No. of patients | 62 | 35 | 27 | ||||
| Technical success | 60/62 | 96.8% | 35/35 | 100.0% | 25/27 | 92.6% | 0.186 |
| Clinical success | 49/62 | 79.0% | 31/35 | 88.6% | 18/27 | 66.7% | 0.03612 |
| Reinterventions (RI) | 15/62 | 24.2% | 11/35 | 31.4% | 4/27 | 14.8% | 0.1302 |
| Early RI (≤ 30 d) | 7/62 | 11.3% | 3/35 | 8.6% | 4/27 | 14.8% | 0.689 |
| Late RI (> 30 d) | 8/62 | 12.9% | 8/35 | 22.9% | 0/27 | 0.0% | 0.0081 |
| Median time to early RI (d) | 6 (3.5-12.5) | 11 (8.5-15.5) | 3.5 (3.0-6.5) | ||||
| Median time to late RI (d) | 130.5 (90.75-220) | 130.5 (90.75-220) | Ø | ||||
| RI after clinical success | 10/49 | 20.4% | 9/31 | 29.0% | 1/18 | 5.6% | 0.070 |
| Early RI (≤ 30 d) | 2/49 | 4.1% | 1/31 | 3.2% | 1/18 | 5.6% | 1.000 |
| Late RI (> 30 d) | 8/49 | 16.3% | 8/31 | 25.8% | 0/18 | 0.0% | 0.0201 |
| RI after clinical failure | 5/13 | 38.5% | 2/4 | 50.0% | 3/9 | 33.3% | 1.000 |
| Early RI (≤ 30 d) | 0/13 | 38.5% | 2/4 | 50.0% | 3/9 | 33.3% | 1.000 |
| Late RI (> 30 d) | 0/13 | 0.0% | 0/4 | 0.0% | 0/9 | 0.0% | |
| Complications | |||||||
| Major | 3/62 | 4.8% | 2/35 | 5.7% | 1/27 | 3.7% | 1.000 |
| Minor | 4/62 | 6.5% | 1/35 | 2.9% | 3/27 | 11.1% | 0.309 |
| Median survival (d) | 57 (19.75-145.25) | 70 (19.5-213.5) | 48 (26-79) | ||||
1
Statistically significant; P-values: Fisher's exact test or
2
χ2 test; Displayed are percentages and numbers or median and quartiles.